Praxis Precision Medicines Inc. (PRAX) PT Raised to $360 at Truist Securities

October 16, 2025 12:31 PM EDT Send to a Friend
Truist Securities analyst Joon Lee raised the price target on Praxis Precision Medicines Inc. (NASDAQ: PRAX) to $360.00 (from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login